Parascript unwraps new AccuDetect release

AuntMinnie.com staff writers
Nov 15, 2011

Computer-aided detection (CAD) developer Parascript has released version 5.0 of its AccuDetect mammography CAD software.

Version 5.0 includes significant performance improvements over the previous release and further reduces the potential for false positives, according to the vendor.

Comments
Unable to load comments: Failed to fetch
Latest in Breast
Clinical workflow with Clairity Breast. Graphic courtesy of Clairity.
Clairity deploys AI for breast cancer risk prediction
June 6, 2025
Korstjens Davin Thumbnail
IMV: Patient satisfaction tops mammography department priorities
June 5, 2025
Pxl 20250531 175048475~2
Mobile mammography units face diagnostic challenges
June 1, 2025
Business Partner Handshake Intelligence
RamSoft to integrate Therapixel's MammoScreen
May 21, 2025
Related Stories
2011 10 10 09 21 51 308 Brown Jerry 70
Breast
Calif. governor vetoes breast density legislation
2011 07 29 08 17 13 510 2011 07 28 Bmj Thumb
Breast
Debate over breast screening to intensify after new BMJ study
2011 06 27 09 36 40 776 Sectra Mammography Unit Thumb
Breast
Sectra to sell mammography business to Philips
2011 05 11 16 02 47 518 Slide 15 Thumb
Breast
DBT beats digital mammo for microcalcifications
More in Breast
Clairity deploys AI for breast cancer risk prediction
By Erik L. Ridley
Clairity believes that its new AI software can deliver improvements over traditional breast cancer risk-prediction models.
June 6, 2025
Clinical workflow with Clairity Breast. Graphic courtesy of Clairity.
IMV: Patient satisfaction tops mammography department priorities
By Davin Korstjens
Mammography departments' top priority is providing patient-centered care.
June 5, 2025
Korstjens Davin Thumbnail
Mobile mammography units face diagnostic challenges
By AuntMinnie.com staff writers
There are opportunities to improve the service provided by mobile mammography units, according to research presented at ASCO 2025 in Chicago.
June 1, 2025
Pxl 20250531 175048475~2
RamSoft to integrate Therapixel's MammoScreen
By AuntMinnie.com staff writers
Commercial partnership adds AI-based breast cancer screening software to RamSoft's platforms.
May 21, 2025
Business Partner Handshake Intelligence
Lunit hits 1M mammogram milestone a year after Volpara purchase
By AuntMinnie.com staff writers
Lunit has achieved the milestone of helping to screen more than 1 million annual mammograms in North America.
May 19, 2025
Lunit
ARRS: Breast RT doesn't impact presence of breast arterial calcifications
By Kate Madden Yee
May 2, 2025
Thumbnail 71 Year Old Patient With History Of Left Breast Invasive Lobular Carcinoma Mindul Thumbnail
Loading Most Popular Stories...
ARRS: How to manage 'controversial' high-risk breast lesions
By Amerigo Allegretto
Managing high-risk breast lesions with no consensus can be tricky, but breast radiologists can navigate this area.
April 30, 2025
Amie Lee, MD, presented at ARRS 2025 on managing 'controversial' high-risk breast lesions diagnosed on core needle biopsy. This slide outlines how to manage pleomorphic lobular carcinoma in situ (LCIS) via surgical excision.
Preop MRI fails to deliver results for breast cancer subtype
Preoperative MRI didn't improve outcomes in women with HER2-positive and hormone receptor-negative breast cancer in a new study.
April 29, 2025
Images show a palpable mass in the left breast in a 55-year-old woman. (A) Mammography shows a 26-mm ill-defined mass with fine linear calcifications in the central portion of the left breast (arrows). (B) ultrasound shows a 23-mm hypoechoic mass with calcifications in the corresponding area accompanying palpability (between the arrows). (C) An axial, fat-saturated, contrast-enhanced T1-weighted MRI scan shows an 18-mm irregular heterogeneous enhancing mass in the left breast (arrows). After breast-conserving surgery, the final pathologic report confirmed a grade II estrogen receptor–negative, progesterone receptor–negative, human epidermal growth factor receptor 2–positive invasive ductal carcinoma. There was no lymphovascular invasion, and the resection margins were clear. The patient declined both adjuvant chemotherapy and radiation therapy due to psychologic distress. (D) 11 months later, surveillance ultrasound helped to detect a new 25-mm irregular hypoechoic mass at the 12-o’clock position in the left breast (arrows). A subsequent ultrasound-guided biopsy confirmed it as a recurrence of grade II invasive ductal carcinoma, maintaining the same receptor statuses. Images courtesy of the RSNA.
iCAD partners with Microsoft on mammography suite integration
By AuntMinnie.com staff writers
iCAD will collaborate with Microsoft on incorporating a set of its AI-driven mammography tools into Microsoft’s Precision Imaging Network.
April 29, 2025
Breast Mammo Computer
ARRS: 'Report Cards' reduce BIRADS 3 usage
By Maryam Payne
"Report cards” were found to reduce rates of BI-RADS 3 assessment use, according to an award-winning poster presentation at ARRS 2025.
April 28, 2025
Breast Specialist Ultrasound Exam 400
Mammo uptake among veterans on par with nonveterans
By Amerigo Allegretto
Female veterans are as likely to undergo screening mammography as nonveteran women.
April 25, 2025
Mammogram Patient
ACS: Breast cancer screening rates have recovered post-COVID
By Kate Madden Yee
Rates of up-to-date breast cancer screening have recovered after declining during the COVID-19 pandemic.
April 23, 2025
Breast Screening Mammo
Page 1 of 572
Next Page